Biocon Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOCON PHARMA, and what generic and branded alternatives to BIOCON PHARMA drugs are available?
BIOCON PHARMA has sixteen approved drugs.
Summary for Biocon Pharma
US Patents: | 0 |
Tradenames: | 15 |
Ingredients: | 15 |
NDAs: | 16 |
PTAB Cases with Biocon Pharma as petitioner: | See PTAB cases with Biocon Pharma as petitioner |
Drugs and US Patents for Biocon Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon Pharma | MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 217031-001 | Nov 29, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209639-002 | Mar 13, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 214630-001 | Nov 29, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 217215-001 | Aug 29, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Biocon Pharma | OXCARBAZEPINE | oxcarbazepine | SUSPENSION;ORAL | 218278-001 | Mar 1, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.